Mana Bio
San Francisco, US · 4 known investors
Mana.bio is a biotech company that uses machine learning and high-throughput screening to design lipid nanoparticles for targeted delivery of nucleic acid therapeutics and vaccines. The company aims to unlock RNA-based treatments for genetic diseases with unmet medical needs.
Founders & leadership
YD.png)
Yogev DebbiinCo-Founder & CEO
RN
Roy NevoFounder
Investors · 4
Andreessen HorowitzMenlo Park · $500K – $50M
LionBirdTel Aviv · $200K – $500K
NFXSan Francisco · $250K – $5M
Also in the syndicate · 1
Base4 Capital
Funding
SEC filings, press & company announcementsSource: company announcements and press reports — follow each round's link for the claim.
Competitors · 4
by search overlap
Nabla Bio7 shared keywordsNabla is a drug development company that applies design discipline and scientific rigor to the development of new medicines. The company focuses on making drug development more systematic and iterative, serving the pharmaceutical and biotech industry.
OmniAb5 shared keywordsOmniAb provides antibody discovery technologies, including proprietary transgenic animals that generate fully human antibodies, to help biopharmaceutical companies and research institutions identify therapeutic candidates. It offers discovery platforms such as xPloration and licenses its technology to over 100 partners worldwide for clinical drug development.
Nosis Bio5 shared keywordsNosis develops a platform for receptor-targeted delivery of RNA therapeutics to specific cell types, addressing a key bottleneck in RNA drug development. The company aims to reduce the cost and timeline of bringing new RNA medicines to market.
Manifold4 shared keywordsManifold Bio combines AI-guided protein design with high-throughput in vivo screening to engineer tissue-targeted biologics and deliver therapeutic payloads to specific organs. The company develops a computational and experimental platform to optimize pharmacokinetics and biodistribution directly in living systems for drug discovery and development.
Companies competing with Mana Bio for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Mana Bio do?
- Mana.bio is a biotech company that uses machine learning and high-throughput screening to design lipid nanoparticles for targeted delivery of nucleic acid therapeutics and vaccines. The company aims to unlock RNA-based treatments for genetic diseases with unmet medical needs.
- Who founded Mana Bio?
- Mana Bio was founded by Yogev Debbi, Roy Nevo.
- Who are Mana Bio's investors?
- Mana Bio's investors include Andreessen Horowitz, LionBird, NFX.
- Where is Mana Bio headquartered?
- Mana Bio is headquartered in San Francisco, US.